Susan M. Domchek

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Germline pathogenic variants in cancer predisposition genes among women with invasive lobular cancer of breast.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10581

Top 100%

0DataRank

Top 100%0 citations

Chunling Hu, Susan M. Domchek, Jeffrey N. Weitzel, David E. Goldgar, Peter Kraft +11 more

Papers

Driven by 85 papers — median percentile 0. Top paper: “The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib”.

The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1467

N/A

0.873DataRank · unranked

24 citations

Arielle Yablonovitch, Jacob E. Till, Jennifer Yen, Lesli A. Kiedrowski, Ryan Hood +9 more

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer

Journal of Clinical Oncology(2020)10.1200/jco.19.02190

N/A

0.709DataRank · unranked

112 citations

Chunling Hu, Steven N. Hart, Nicholas Boddicker, Eric C. Polley, Jie Na +22 more

A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152)

Cancer(2021)10.1002/cncr.34063

N/A

0.616DataRank · unranked

15 citations

Ju‐Whei Lee, Jill B. Gaieski, Shuli Li, Ilana F. Gareen, Keith T. Flaherty +15 more

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

Communications Biology(2022)10.1038/s42003-022-03978-6

N/A

0.607DataRank · unranked

15 citations

John F. Pearson, Louise Marquart, Joe Dennis, George A. R. Wiggins, Daniel R. Barnes +95 more

Breast and Prostate Cancer Risks for MaleBRCA1andBRCA2Pathogenic Variant Carriers Using Polygenic Risk Scores

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab147

N/A

0.571DataRank · unranked

44 citations

Valentina Silvestri, Goska Leslie, Lesley McGuffog, Joe Dennis, Xin Yang +95 more

Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer

UNC Libraries(2020)10.17615/45kg-tz48

N/A

0.551DataRank · unranked

9 citations

Oladosu Ojengbede, Jennifer J. Hu, Christine B. Ambrosone, Kathryn L. Lunetta, Stephen A. Haddad +42 more

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

UNC Libraries(2020)10.17615/bg56-kz70

N/A

0.449DataRank · unranked

19 citations

Trinidad Caldés, Maria A. Caligo, Alessandra Viel, Susan J. Ramus, Kathleen Claes +95 more

Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0594

N/A

0.408DataRank · unranked

8 citations

Nicholas Boddicker, Siddhartha Yadav, Hongyan Huang, Jie Na, Chunling Hu +30 more

APOLLO: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1, BRCA2 or PALB2 mutation—ECOG-ACRIN EA2192.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps763

N/A

0.330DataRank · unranked

8 citations

Sung Chul Hong, Anup Kasi, Eileen M. O’Reilly, Shishir K. Maithel, Xin Yao +10 more

Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.14.571597

N/A

0.269DataRank · unranked

5 citations

Chunling Hu, Jie Na, Steven N. Hart, Rohan Gnanaolivu, Mohamed Abozaid +18 more

A Rare TP53 Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple Cancers

Cancer Research(2020)10.1158/0008-5472.can-20-1390

N/A

0DataRank · unranked

28 citations

Emília M. Pinto, Thibaut Barnoud, Jessica C. Leung, Tetyana Martynyuk, Andrew V. Kossenkov +31 more

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

UNC Libraries(2020)10.17615/9br1-ag80

N/A

0DataRank · unranked

2 citations

Paolo Peterlongo, María‐Isabel Tejada, Per Karlsson, Thomas van Overeem Hansen, Susan M. Domchek +95 more

Randomized trial of web-based genetic education versus usual care in advanced cancer patients undergoing tumor genetic testing: Results from the ECOG-ACRIN NCI Community Oncology Research Program (NCORP; EAQ152) COMET trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2008

N/A

0DataRank · unranked

0 citations

Ju‐Whei Lee, Jill B. Gaieski, Shuli Li, Ilana F. Gareen, Keith T. Flaherty +15 more

Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status

UNC Libraries(2020)10.17615/6wxj-0g75

N/A

0DataRank · unranked

0 citations

Claudine Isaacs, Patrick M. Sluss, Phuong Mai, Wendy R. Brewster, Gustavo C. Rodriguez +25 more

Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis

UNC Libraries(2020)10.17615/7epw-8t59

N/A

0DataRank · unranked

0 citations

Eunjung Lee, Patricia G. Moorman, Dianne M. Finkelstein, P. Kelly Marcom, Banu Arun +15 more

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

UNC Libraries(2020)10.17615/181h-6e37

N/A

0DataRank · unranked

0 citations

Penny Soucy, Anna Jakubowska, Xianshu Wang, Susan M. Domchek, Paolo Radice +27 more

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers

UNC Libraries(2020)10.17615/ndzd-wt90

N/A

0DataRank · unranked

0 citations

Katja Harbst, Maria A. Caligo, Nathanson, Kate, Sue Healey, Karoline Kuchenbaecker +15 more

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

UNC Libraries(2020)10.17615/2xde-se42

N/A

0DataRank · unranked

0 citations

Phuong L. Mai, David S. Alberts, William J. Welch, Carol J. Fabian, Mary B. Daly +32 more

A Population-Based Study of Genes Previously Implicated in Breast Cancer

New England Journal of Medicine(2021)10.1056/nejmoa2005936

N/A

0DataRank · unranked

878 citations

Steven N. Hart, Rohan Gnanaolivu, Hongyan Huang, Kun Y. Lee, Jie Na +55 more

Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.08.024

N/A

0DataRank · unranked

117 citations

Stephanie L. Wethington, Cheyenne Pagan, Nawar Latif, János L. Tanyi, Lainie P. Martin +17 more

Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score

Journal of Clinical Oncology(2021)10.1200/jco.20.01992

N/A

0DataRank · unranked

95 citations

Eric C. Polley, Steven N. Hart, Hongyan Huang, Chunling Hu, Rohan Gnanaolivu +37 more

Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast

Journal of Clinical Oncology(2021)10.1200/jco.21.00640

N/A

0DataRank · unranked

51 citations

Chunling Hu, Katherine L. Nathanson, Jeffrey N. Weitzel, David E. Goldgar, Peter Kraft +37 more

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Genetics in Medicine(2021)10.1038/s41436-021-01198-7

N/A

0DataRank · unranked

40 citations

Alexandra J. van den Broek, Julien A M Vos, Daniel R. Barnes, Julian Adlard, Irene L. Andrulis +95 more

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

Genetics in Medicine(2021)10.1016/j.gim.2021.08.016

N/A

0DataRank · unranked

30 citations

Christoph Engel, Miguel de la Hoya, Paolo Peterlongo, Drakoulis Yannoukakos, Luca Livraghi +56 more

First international workshop of the ATM and cancer risk group (4-5 December 2019)

Familial Cancer(2021)10.1007/s10689-021-00248-y

N/A

0DataRank · unranked

19 citations

Douglas F. Easton, Anne‐Laure Renault, Sean V. Tavtigian, Jonine L. Bernstein, Zsofia Kote‐Jarai +51 more

EUS-based Pancreatic Cancer Surveillance in BRCA1/BRCA2/PALB2/ATM Carriers Without a Family History of Pancreatic Cancer

Cancer Prevention Research(2021)10.1158/1940-6207.capr-21-0161

N/A

0DataRank · unranked

10 citations

Jessica M. Long, Nuzhat A. Ahmad, Sara Attalla, Angela R. Bradbury, Erica L. Carpenter +16 more

Polygenic Risk Scores for Prediction of Breast Cancer Risk in Women of African Ancestry: a Cross-Ancestry Approach

medRxiv(2021)10.1101/2021.12.16.21266424

N/A

0DataRank · unranked

2 citations

Fangyuan Zhao, Thomas U. Ahearn, Kathryn L. Lunetta, Melissa A. Troester, Zhaohui Du +52 more

Germline pathogenic variants in cancer predisposition genes among women with invasive lobular cancer of breast.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10581

Top 100%

0DataRank

Top 100%0 citations

Chunling Hu, Susan M. Domchek, Jeffrey N. Weitzel, David E. Goldgar, Peter Kraft +11 more

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.159

N/A

0DataRank · unranked

450 citations

Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross +93 more

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

European Journal of Human Genetics(2022)10.1038/s41431-021-00987-7

N/A

0DataRank · unranked

73 citations

Jonathan P. Tyrer, Daniel R. Barnes, Michelle R. Jones, Xin Yang, Katja K. H. Aben +90 more

Impact of integrating genomic data into the electronic health record on genetics care delivery

Genetics in Medicine(2022)10.1016/j.gim.2022.08.009

N/A

0DataRank · unranked

42 citations

Danielle McKenna, Stephanie Asher, Tanya Bardakjian, Colin Wollack, Joseph Bleznuck +19 more

Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach

Human Molecular Genetics(2022)10.1093/hmg/ddac102

N/A

0DataRank · unranked

27 citations

Fangyuan Zhao, Thomas U. Ahearn, Kathryn L. Lunetta, Melissa A. Troester, Zhaohui Du +52 more

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0203

N/A

0DataRank · unranked

22 citations

Lisa R. Susswein, Maegan E. Roberts, Hana Yang, Megan L. Marshall, Susan Hiraki +14 more

BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors

Frontiers in Cardiovascular Medicine(2022)10.3389/fcvm.2022.833171

N/A

0DataRank · unranked

7 citations

Wenjian Lv, Nicholas S. Wilcox, Karyn Sheline, Amanda M. Smith, Kathleen M. Sturgeon +7 more

Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood

Clinical Genetics(2022)10.1111/cge.14231

N/A

0DataRank · unranked

4 citations

Vishal Patel, Kevin T. Nead, Shana L. Merrill, Dana Clark, Qinqin Jiang +9 more

A descriptive study on the treatment and outcomes of patients with platinum-sensitive, advanced, BRCA- or PALB2-related pancreatic cancer who have progressed on rucaparib.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4131

N/A

0DataRank · unranked

2 citations

Mark H. O’Hara, Ursina Teitelbaum, Thomas B. Karasic, Charles Schneider, Natallia Izgur +4 more

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

Research Square(2022)10.21203/rs.3.rs-2269143/v1

N/A

0DataRank · unranked

0 citations

Anna Morra, Sofia Khan, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis +64 more

Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants inATM,BRCA1,BRCA2,CHEK2, andPALB2

Journal of Clinical Oncology(2023)10.1200/jco.22.01239

N/A

0DataRank · unranked

175 citations

Nicholas Boddicker, Jie Na, Eric C. Polley, Chunling Hu, Steven N. Hart +31 more

OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

European Journal of Cancer(2023)10.1016/j.ejca.2023.01.031

N/A

0DataRank · unranked

113 citations

Seock‐Ah Im, Elżbieta Senkus, Binghe Xu, Susan M. Domchek, Norikazu Masuda +8 more

C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2444

N/A

0DataRank · unranked

79 citations

Payal D. Shah, Lainie P. Martin, János L. Tanyi, Nawar Latif, Mark A. Morgan +14 more

Care after premenopausal risk‐reducing salpingo‐oophorectomy in high‐risk women: Scoping review and international consensus recommendations

BJOG An International Journal of Obstetrics & Gynaecology(2023)10.1111/1471-0528.17511

N/A

0DataRank · unranked

34 citations

Susan M. Domchek, Joanne Kotsopoulos, Joanne A. de Hullu, Emma J. Crosbie, Vincent Singh Paramanandam +22 more

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles

Nature Communications(2023)10.1038/s41467-023-38925-4

N/A

0DataRank · unranked

20 citations

Urszula Smyczyńska, Konrad Stawiski, Zuzanna Nowicka, James W. Webber, Jakub Kaplan +12 more

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

British Journal of Cancer(2023)10.1038/s41416-023-02263-5

N/A

0DataRank · unranked

19 citations

Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John +87 more

Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education

Journal of Clinical Oncology(2023)10.1200/jco.22.00516

N/A

0DataRank · unranked

11 citations

Brian L. Egleston, Wendy K. Chung, Olufunmilayo I. Olopade, Kara N. Maxwell, Payal D. Shah +24 more

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

npj Breast Cancer(2023)10.1038/s41523-023-00546-x

N/A

0DataRank · unranked

7 citations

Anna Morra, Sofia Khan, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis +65 more

Measuring high‐risk parents' opinions about direct‐to‐consumer genetic testing for adult‐onset inherited cancer syndromes in their adolescent and young adult children

Journal of Genetic Counseling(2023)10.1002/jgc4.1685

N/A

0DataRank · unranked

3 citations

Beth N. Peshkin, Jada G. Hamilton, Jamie Brower, Hannah Ovadia, Lainie Friedman Ross +10 more

Development of an Electronic Health Record–Based Clinical Decision Support Tool for Patients With Lynch Syndrome

JCO Clinical Cancer Informatics(2023)10.1200/cci.23.00024

N/A

0DataRank · unranked

2 citations

Joseph Bleznuck, Colin Wollack, Danielle McKenna, Jessica M. Long, Anna P. Hubert +12 more

Apollo: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1, BRCA2, or PALB2 mutation—ECOG-ACRIN EA2192.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4202

N/A

0DataRank · unranked

3 citations

Sung Chul Hong, Anup Kasi, Eileen M. O’Reilly, Shishir K. Maithel, Xin Yao +10 more

The identification of reversion mutations in patients with advanced pancreatic cancer and germline or somatic BRCA or PALB2 variants who were treated with maintenance rucaparib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.734

N/A

0DataRank · unranked

1 citations

Arielle Yablonovitch, Jennifer Yen, Lesli A. Kiedrowski, Erica L. Carpenter, Katherine L. Nathanson +3 more

Data from Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers

(2023)10.1158/0008-5472.c.6499160.v1

N/A

0DataRank · unranked

0 citations

Nandita Mitra, Susan M. Domchek, Fei Wan, Shannon Chuai, Tara M. Friebel +22 more

Data from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

(2023)10.1158/1078-0432.c.6532509.v1

Top 100%

0DataRank

Top 100%0 citations

Lisa R. Susswein, Maegan E. Roberts, Hana Yang, Megan L. Marshall, Susan Hiraki +14 more

Supplementary Table from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Figshare(2023)10.1158/1078-0432.22487391.v1

Top 100%

0DataRank

Top 100%0 citations

Lisa R. Susswein, Maegan E. Roberts, Hana Yang, Megan L. Marshall, Susan Hiraki +14 more

Breast cancer risk associated with missense variants in BRCA2.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10501

N/A

0DataRank · unranked

0 citations

Marcy E. Richardson, Rachid Karam, Nicholas Boddicker, Chunling Hu, Yohannes A. Tecleab +6 more

Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants

Research Square(2023)10.21203/rs.3.rs-3736200/v1

N/A

0DataRank · unranked

0 citations

Huaizhi Huang, Chunling Hu, Jie Na, Steven N. Hart, Rohan Gnanaolivu +18 more

Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0393

N/A

0DataRank · unranked

55 citations

Akshaya V. Annapragada, Pien Lof, Sarah Short, Adrianna L. Bartolomucci, Dimitrios Mathios +30 more

Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.02.002

N/A

0DataRank · unranked

17 citations

Huaizhi Huang, Jie Na, Carolyn A. Lumby, Mohamed Abozaid, Megan Holdren +21 more

Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1884

N/A

0DataRank · unranked

11 citations

Ronan E. Couch, Rachid Karam, Chunling Hu, Nicholas Boddicker, Eric C. Polley +37 more

Facilitating return of actionable genetic research results from a biobank repository: Participant uptake and utilization of digital interventions

Human Genetics and Genomics Advances(2024)10.1016/j.xhgg.2024.100346

N/A

0DataRank · unranked

2 citations

Elisabeth Wood, Brian L. Egleston, Lily Hoffman‐Andrews, Demetrios Ofidis, Sarah Howe +14 more

Pilot implementation study of a default genetic referral process for patients with early-onset colorectal cancer

Genetics in Medicine Open(2024)10.1016/j.gimo.2024.101902

N/A

0DataRank · unranked

1 citations

Shavon E. Rochester, Megan Grabill, Jessica M. Long, Danielle McKenna, Jacqueline Powers +9 more

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk

medRxiv(2024)10.1101/2024.02.29.24303243

N/A

0DataRank · unranked

3 citations

Jonathan P. Tyrer, Joe Dennis, Goska Leslie, Manjeet K. Bolla, Michael Lush +95 more

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification

medRxiv(2024)10.1101/2024.09.04.24313051

N/A

0DataRank · unranked

3 citations

Denise G O'Mahony, Michael T. Parsons, Leila Dorling, Joe Dennis, Nicholas Boddicker +95 more

Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.10511

N/A

0DataRank · unranked

0 citations

Huaizhi Huang, Tina Pesaran, Rachid Karam, Siddhartha Yadav, Susan M. Domchek +6 more

Functional evaluation and clinical classification of BRCA2 variants

Nature(2025)10.1038/s41586-024-08388-8

N/A

0DataRank · unranked

55 citations

Chunling Hu, Jie Na, Steven N. Hart, Rohan Gnanaolivu, Mohamed Abozaid +39 more

Association of gene variant type and location with breast cancer risk in the general population

Annals of Oncology(2025)10.1016/j.annonc.2025.04.010

N/A

0DataRank · unranked

8 citations

Nicholas Boddicker, Siddhartha Yadav, Cai-Xia Hu, Steven N. Hart, Christine B. Ambrosone +40 more

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification

Nature Communications(2025)10.1038/s41467-025-59979-6

N/A

0DataRank · unranked

8 citations

Denise G O'Mahony, Michael T. Parsons, Leila Dorling, Joe Dennis, Nicholas Boddicker +94 more

Comprehensive RAD51C ovarian cancer variant analysis uncouples homologous recombination and replicative functions

Nature Communications(2025)10.1038/s41467-025-61283-2

N/A

0DataRank · unranked

7 citations

Yashpal Rawal, Anna L Palovcak-Lightbourn, Gayatri S. Ganesan, Phoebe S. Parker, Reagan A Russell +15 more

Parental Communication With their Children about Cancer Risk and DTC Cascade Genetic Testing: Implications for Genetic Education and Counseling

American Journal of Medical Genetics Part A(2025)10.1002/ajmg.a.64115

N/A

0DataRank · unranked

2 citations

Talia Zamir, Beth N. Peshkin, Jada G. Hamilton, Mingqian Liu, Mary Rose Yockel +10 more

Pediatric DTC Genetic Testing for Adult-Onset Inherited Cancer Risk: The Perspectives of High-Risk Parents

Public Health Genomics(2025)10.1159/000543913

N/A

0DataRank · unranked

1 citations

Beth N. Peshkin, Jada G. Hamilton, Jamie Brower, Hannah Ovadia, Lainie Friedman Ross +12 more

Racial Differences in Screening Eligibility by Breast Density After State-Level Insurance Expansion

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.25216

N/A

0DataRank · unranked

1 citations

Sarah Ehsan, Sara P. Ginzberg, Susan M. Domchek, Katherine L. Nathanson, Emily F. Conant +6 more

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer

The Breast(2025)10.1016/j.breast.2025.104619

N/A

0DataRank · unranked

1 citations

Gisella Figlioli, Clémence Mooser, Irene Casamassima, Violette Azzoni, Jahnavi Srivatsa +95 more

The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in BRCA1/2 Carriers

medRxiv(2025)10.1101/2025.11.10.25339918

N/A

0DataRank · unranked

1 citations

C.M. Salafia, Rania Sheikh, Elizabeth Schofield, Dana Clark, Jessica Ebrahimzadeh +16 more

Data Supplement 1 from Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast

Figshare(2025)10.1158/1078-0432.28141741

Top 100%

0DataRank

Top 100%0 citations

Ronan E. Couch, Rachid Karam, Chunling Hu, Nicholas Boddicker, Eric C. Polley +37 more

An electronic review of clinical outcomes after return of actionable genetic research results from a health system research biobank

European Journal of Medical Genetics(2025)10.1016/j.ejmg.2025.105061

N/A

0DataRank · unranked

0 citations

Lillian Phung, Elisabeth Wood, Brian L. Egleston, Lily Hoffman‐Andrews, SJ Brown +15 more

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

npj Genomic Medicine(2025)10.1038/s41525-025-00529-w

N/A

0DataRank · unranked

0 citations

Jonathan P. Tyrer, Joe Dennis, Goska Leslie, Manjeet K. Bolla, Michael Lush +95 more

Author Index Vol. 13, No. 7–8, 2010

Public Health Genomics(2010)10.1159/000322612

N/A

0DataRank · unranked

0 citations

T.E. Jayaratne, Poupak Javaher, Elisabeth Nyoungui, L. Ioannou, John Massie +103 more

Clinical trial protocol1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

10.1158/1078-0432.23814207.v1

N/A

0DataRank · unranked

0 citations

Payal D. Shah, Lainie P. Martin, János L. Tanyi, Nawar Latif, Mark A. Morgan +14 more

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Nature Genetics(2020)10.1038/s41588-019-0537-1

N/A

0DataRank · unranked

189 citations

Laura Fachal, EMBRACE Collaborators, KConFab Investigators, HEBON Investigators, ABCTB Investigators +95 more

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa030

N/A

0DataRank · unranked

166 citations

Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber +56 more

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Nature Genetics(2020)10.1038/s41588-020-0609-2

N/A

0DataRank · unranked

578 citations

Thomas U. Ahearn, Julie Lecarpentier, Daniel R. Barnes, Jonathan Beesley, Guanghao Qi +95 more

Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa040

N/A

0DataRank · unranked

78 citations

Eric C. Polley, Chunling Hu, Esther M. John, Christopher A. Haiman, Steven N. Hart +27 more

Characterization of the Cancer Spectrum in Men With GermlineBRCA1andBRCA2Pathogenic Variants

JAMA Oncology(2020)10.1001/jamaoncol.2020.2134

N/A

0DataRank · unranked

67 citations

Goska Leslie, Daniel R. Barnes, and the CIMBA Group, Bjarni A. Agnarsson, Kristiina Aittomäki +95 more

Real-world integration of genomic data into the electronic health record: the PennChart Genomics Initiative

Genetics in Medicine(2020)10.1038/s41436-020-01056-y

N/A

0DataRank · unranked

61 citations

Stephanie Asher, Jessica Chen, Susan M. Domchek, Michael D. Feldman, Steven Joffe +8 more

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-00185-6

N/A

0DataRank · unranked

10 citations

Sofia Khan, Rainer Fagerholm, Kristiina Aittomäki, Julie M. Cunningham, Joe Dennis +39 more

Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

Genetic Epidemiology(2020)10.1002/gepi.22288

N/A

0DataRank · unranked

45 citations

Alexander Gusev, Bogdan Paşaniuc, Lang Wu, Jirong Long, Zomoroda Abu-Full +95 more

Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer

Genetics in Medicine(2020)10.1038/s41436-020-0753-1

N/A

0DataRank · unranked

44 citations

Scott T. Michalski, Rashmi Tondon, Bita Nehoray, Jessica Ebrahimzadeh, Sarah Hughes +7 more

Susan M. Domchek

Indexed papers

Top data-sharing exemplar

Papers